ÖZKAN, B. Et Al. 2011. PAI 4G 5G mutation may predict failure of thromblytic therapy in patients with ST elevation myocardial infarction. European Society of Cardiology Congress , 1058.

ÖZKAN, B., KALKAN, G. Y., ÇAĞLIYAN, Ç. E., KOÇ, M., AKILLI, R., ELBASAN, Z., ... ŞAHİN, D. Y.(2011). PAI 4G 5G mutation may predict failure of thromblytic therapy in patients with ST elevation myocardial infarction . European Society of Cardiology Congress (pp.1058).

ÖZKAN, BUĞRA Et Al. "PAI 4G 5G mutation may predict failure of thromblytic therapy in patients with ST elevation myocardial infarction," European Society of Cardiology Congress, 2011

ÖZKAN, BUĞRA Et Al. "PAI 4G 5G mutation may predict failure of thromblytic therapy in patients with ST elevation myocardial infarction." European Society of Cardiology Congress , pp.1058, 2011

ÖZKAN, B. Et Al. (2011) . "PAI 4G 5G mutation may predict failure of thromblytic therapy in patients with ST elevation myocardial infarction." European Society of Cardiology Congress , p.1058.

@conferencepaper{conferencepaper, author={BUĞRA ÖZKAN Et Al. }, title={PAI 4G 5G mutation may predict failure of thromblytic therapy in patients with ST elevation myocardial infarction}, congress name={European Society of Cardiology Congress}, city={}, country={}, year={2011}, pages={1058} }